Portugal – Antineoplastic and immunomodulating agents – 2025/1303 - DUPILUMAB [300 MG/ 2 ML SOL INJ CANETA]

Unlock Full Tender Insight

Complete details, deadlines, and AI-powered analysis are available inside the tend.ee platform. Create your free account to access.

It's free to get started. No credit card required.